Loading song details...
David R Gandara MD On Whether Keynote 189 Impacted View Of PDL 1 Expression And Patient Selection
No description available.
MP3 Download
Video Download
Related Songs
2:03
Dr David Gandara Discusses Multiplexing Molecular Tests For NSCLC
0:46
David Gandara MD Discusses Considerations When Choosing Between Immunotherapy And Chemotherapy
0:44
David R Gandara MD Discusses Exciting New Developments In Lung Cancer Here At ASCO 2018
2:22
Dr Gandara On How Lung MAP Trial Is Optimal For Patient Care
1:02
David R Gandara MD Invites You To The 23rd Annual International Lung Cancer Congress 7 28 30
1:20
Dr David Gandara Describes Exciting New Lung Cancer Research
1:34
Dr David Gandara On Patient Selection For Molecular Testing In Lung Cancer
1:06
Dr Gandara On Recent Advancements In Field Of Lung Cancer
1:02
Dr Gandara On The MYSTIC Trial For Lung Cancer
2:38
Living Room Highlights Determining Whether To Use A Solid Or Liquid Biopsy In The Time Of COVID
37:57
Rapid Response Living Room Lung Cancer Is Not Taking A Back Seat Care Must Go On 05 20
28:53
THE LUNG CANCER LIVING ROOM PERSONALIZING YOUR CARE DR DAVID GANDARA FEB 19 2013
1:41
David R Gandara MD Discusses Drug Sequencing As A Result Of Keynote 189 And 42 Results
0:59
David Gandara MD Discusses The Positioning Of Cyramza Post Platinum Therapy In NSCLC Patients
1:30
David R Gandara MD On Whether Keynote 189 Impacted View Of PDL 1 Expression And Patient Selection
1:55
Dr Gandara On The Impact Of Immunotherapy Tumor Microenvironment In Lung Cancer
1:16
Dr Gandara Discusses Clinical Implications Of The FLAURA Study In NSCLC
1:16
Dr Gandara Discusses Third Generation EGFR TKIs
18:01
Lung Cancer Voices Podcast Advances In Achievements Hopes And Challenges
2:15